TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | -2 | -1 | -14 | -16 | -55 | 0 | -17 |
| S | %wins | 100 | 50 | 100 | 100 | 100 | 90 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/30/16 19:56 | 11/28/16 | ARLZ | Aralez Pharmaceuticals Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Harris Robert Paul | A6 | D | M.dm | 489 | 3.92 | 3 | 125 | 12 | 1,194 | D | -43 | -33 | 24 | 1 | 6 | 27 | -2 | 11 | 0 | 2 | -13 | -22 | |||
11/30/16 19:56 | 11/28/16 | ARLZ | Aralez Pharmaceuticals Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Harris Robert Paul | A6 | D | S.dm | -616 | 4.94 | 3 | -125 | -9 | 1,194 | D | -43 | -33 | 24 | 1 | 6 | 27 | -2 | 11 | 0 | 2 | -13 | -22 | |||
9/19/16 19:57 | 9/15/16 | ARLZ | Aralez Pharmaceuticals Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Harris Robert Paul | A6 | D | S | -873 | 5.82 | 11 | -150 | -11 | 1,194 | D | -31 | -43 | 52 | 64 | 46 | 12 | 0 | -8 | -3 | -3 | -14 | -10 | -55 | ||
3/20/13 19:42 | 3/22/12 | TBUFF | Tribute Pharmaceuticals Canada Inc. | A6 | Health | Drug | Pharmaceutical Preparations | Harris Robert Paul | A6 | DO | CEO | P.dm | 866 | 0.5020 | 0 | 1,725 | 11 | 17,125 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |